4-(5-((2-Chloroethyl)(2-((2,3-dihydroxypropyl)thio)ethyl)amino)-1-methyl-1H-benzo(d)imidazol-2-yl)butanoic acid
Bendamustine Impurity 19 is listed by Simson Pharma as a impurity standards for laboratory research, analytical development and quality-control workflows.
Suitability is method- and purpose-specific. Before use, verify the product name, catalogue number, chemical identifiers, storage requirements and the information reported in the current product or batch documentation. Your laboratory remains responsible for method qualification or validation.
Buy 3543-73-5 Purchase 3543-73-5 Order 3543-73-5 Enquire 3543-73-5 3543-73-5 price 3543-73-5 supplier 3543-73-5 manufacturer 3543-73-5 exporter Bendamustine Impurity 19 for method validation Bendamustine Impurity 19 reference standard Bendamustine Impurity 19 for ANDA filing Bendamustine Impurity 19 for forced degradation studies Bendamustine Impurity 19 identification standard Bendamustine Impurity 19 for DMF filing Bendamustine Impurity 19 HPLC standard Bendamustine Impurity 19 supplier Bendamustine Impurity 19 manufacturer Bendamustine Impurity 19 distributor
